Liquid biopsy uncovers distinct patterns of DNA methylation and copy number changes in NSCLC patients with different EGFR-TKI resistant mutations

Targeted therapy with tyrosine kinase inhibitors (TKI) provides survival benefits to a majority of patients with non-small cell lung cancer (NSCLC). However, resistance to TKI almost always develops after treatment. Although genetic and epigenetic alterations have each been shown to drive resistance...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Hoai-Nghia, Cao, Ngoc-Phuong Thi, Van Nguyen, Thien-Chi, Le, Khang Nguyen Duy, Nguyen, Dat Thanh, Nguyen, Quynh-Tho Thi, Nguyen, Thai-Hoa Thi, Van Nguyen, Chu, Le, Ha Thu, Nguyen, Mai-Lan Thi, Nguyen, Trieu Vu, Tran, Vu Uyen, Luong, Bac An, Le, Linh Gia Hoang, Ho, Quoc Chuong, Pham, Hong-Anh Thi, Vo, Binh Thanh, Nguyen, Luan Thanh, Dang, Anh-Thu Huynh, Nguyen, Sinh Duy, Do, Duc Minh, Do, Thanh-Thuy Thi, Hoang, Anh Vu, Dinh, Kiet Truong, Phan, Minh-Duy, Giang, Hoa, Tran, Le Son
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8361064/
https://www.ncbi.nlm.nih.gov/pubmed/34385540
http://dx.doi.org/10.1038/s41598-021-95985-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8361064/
https://www.ncbi.nlm.nih.gov/pubmed/34385540
http://dx.doi.org/10.1038/s41598-021-95985-6

Ejemplares similares